secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001193125-25-121677
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences closes $69.9M public offering of common stock and warrants
---------------------------------------------------------------------------

- Sold 11.7M shares, 3.6M pre-funded warrants, and 3.8M common stock warrants at $4.90 combined price.
- Net proceeds of approximately $69.9 million after underwriting discounts and expenses.
- Proceeds to advance clinical programs in choroidal melanoma, ocular surface cancers, and bladder cancer.
- Cash runway extended into the first half of 2027.
- Offering closed on May 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312525121677/0001193125-25-121677-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312525121677/d213451d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-121677

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer